HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Roland W Herzog Selected Research
Roland W Herzog Research Topics
Disease
37
Hemophilia B (Haemophilia B)
10/2021 - 04/2002
32
Hemophilia A (Haemophilia)
07/2022 - 04/2004
20
Hemorrhage
01/2022 - 08/2004
11
Inborn Genetic Diseases (Disease, Hereditary)
01/2021 - 05/2003
10
Glycogen Storage Disease Type II (Pompe's Disease)
12/2017 - 04/2011
7
Anaphylaxis (Anaphylactic Shock)
11/2015 - 04/2010
6
Autoimmune Diseases (Autoimmune Disease)
01/2021 - 10/2007
4
Protein Deficiency
11/2013 - 08/2004
3
Inflammation (Inflammations)
11/2021 - 01/2014
2
Neoplasms (Cancer)
01/2021 - 01/2009
2
Hypersensitivity (Allergy)
11/2019 - 04/2010
2
Graft vs Host Disease (Graft-Versus-Host Disease)
01/2019 - 07/2014
2
Nephrotic Syndrome (Syndrome, Nephrotic)
11/2015 - 11/2013
1
Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
11/2021
1
Food Hypersensitivity (Food Allergy)
01/2021
1
Liver Diseases (Liver Disease)
01/2020
1
Peanut Hypersensitivity (Peanut Allergy)
11/2019
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2019
1
Experimental Melanoma
01/2019
1
Persistent Infection
01/2017
1
Hematologic Neoplasms (Hematological Malignancy)
01/2016
1
Primary Immunodeficiency Diseases
01/2016
1
Hemoglobinopathies
01/2016
1
Type 1 Diabetes Mellitus (Autoimmune Diabetes)
07/2014
1
Disseminated Intravascular Coagulation
01/2014
1
Muscle Weakness
06/2012
1
Neuromuscular Diseases (Neuromuscular Disease)
06/2012
1
Colitis
03/2012
1
Muscular Diseases (Myopathy)
04/2011
1
Infections
03/2011
1
Necrosis
04/2010
1
Neuroinflammatory Diseases
10/2008
1
Severe combined immunodeficiency due to adenosine deaminase deficiency
07/2003
Drug/Important Bio-Agent (IBA)
37
Factor IX (Coagulation Factor IX)
FDA Link
Generic
10/2021 - 04/2002
24
Proteins (Proteins, Gene)
FDA Link
01/2022 - 04/2004
16
Factor VIII (Coagulation Factor VIII)
IBA
07/2022 - 04/2004
15
Antibodies
IBA
01/2022 - 04/2004
12
Blood Coagulation Factors (Coagulation Factor)
IBA
01/2022 - 03/2005
9
Pharmaceutical Preparations
IBA
10/2021 - 06/2015
9
Antigens
IBA
01/2021 - 08/2004
9
Acids
IBA
01/2016 - 04/2011
6
alpha-Glucosidases (Acid Maltase)
IBA
12/2017 - 04/2011
5
Glycogen
IBA
01/2016 - 04/2011
5
Enzymes
IBA
01/2016 - 03/2005
4
Immunoglobulin E (IgE)
IBA
01/2017 - 06/2012
4
Glucosidases
IBA
01/2016 - 06/2012
3
Sirolimus (Rapamycin)
FDA Link
07/2022 - 09/2013
3
human GAA protein (Myozyme)
FDA Link
10/2015 - 06/2012
2
Prednisolone (Predate)
FDA Link
Generic
11/2021 - 06/2017
2
Cholera Toxin
IBA
10/2021 - 04/2015
2
Immunoglobulin G (IgG)
IBA
01/2017 - 06/2012
2
Tyrosine (L-Tyrosine)
FDA Link
01/2017 - 01/2012
2
Antigen-Antibody Complex (Immune Complex)
IBA
01/2017 - 04/2015
2
Codon (Codons)
IBA
09/2015 - 01/2012
2
Glucocorticoids
IBA
03/2012 - 04/2010
2
Neutralizing Antibodies
IBA
01/2012 - 01/2012
1
Interleukin-15 (Interleukin 15)
IBA
07/2022
1
Autoantibodies
IBA
01/2022
1
Alkaline Phosphatase
IBA
11/2021
1
Dystrophin
IBA
11/2021
1
Ointments (Pastes)
IBA
01/2021
1
Cell Surface Receptors
IBA
01/2019
1
Ovalbumin
IBA
01/2019
1
Isoantibodies
IBA
01/2018
1
Complementary DNA (cDNA)
IBA
01/2016
1
Desmin
IBA
09/2015
1
B-Cell Activating Factor
IBA
06/2015
1
Interleukin-10 (Interleukin 10)
IBA
04/2015
1
Immunoglobulins (Immunoglobulin)
IBA
04/2015
1
Dacarbazine (DIC)
FDA Link
Generic
01/2014
1
Type 1 Angiotensin Receptor
IBA
01/2014
1
Rituximab (Mabthera)
FDA Link
09/2013
1
Cytokines
IBA
03/2012
1
Ligands
IBA
03/2012
1
Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
IBA
03/2012
1
Enzyme Precursors (Zymogens)
IBA
01/2012
1
DNA (Deoxyribonucleic Acid)
IBA
01/2012
1
Lipofectamine
IBA
03/2011
1
Bile Acids and Salts (Bile Acids)
IBA
01/2009
1
Autoantigens
IBA
10/2007
1
T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)
IBA
07/2006
1
Peptides (Polypeptides)
IBA
07/2006
1
Nonsense Codon (Nonsense Mutation)
IBA
11/2005
1
Adenosine Deaminase
IBA
07/2003
1
N-acetyltalosaminuronic acid (NAT)
IBA
07/2002
1
A-factor (Streptomyces)
IBA
04/2002
Therapy/Procedure
36
Therapeutics
01/2022 - 05/2003
4
Enzyme Replacement Therapy
10/2015 - 09/2013
4
Intramuscular Injections
03/2005 - 07/2002
3
Injections
01/2020 - 04/2010
2
Immunotherapy
01/2021 - 11/2019
2
Cell- and Tissue-Based Therapy (Cell Therapy)
06/2017 - 07/2014
1
Investigational Therapies (Experimental Therapy)
01/2017
1
Liver Transplantation
01/2017
1
Intravenous Infusions
03/2016
1
Bone Marrow Transplantation (Transplantation, Bone Marrow)
07/2014
1
Immunomodulation
09/2013
1
Intranasal Administration
07/2006